FR2607719B1 - Microcristaux comportant a titre de substance active des ginkgolides et compositions pharmaceutiques les contenant - Google Patents

Microcristaux comportant a titre de substance active des ginkgolides et compositions pharmaceutiques les contenant

Info

Publication number
FR2607719B1
FR2607719B1 FR8617116A FR8617116A FR2607719B1 FR 2607719 B1 FR2607719 B1 FR 2607719B1 FR 8617116 A FR8617116 A FR 8617116A FR 8617116 A FR8617116 A FR 8617116A FR 2607719 B1 FR2607719 B1 FR 2607719B1
Authority
FR
France
Prior art keywords
ginkgolides
microcrystals
pharmaceutical compositions
active substance
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8617116A
Other languages
English (en)
Other versions
FR2607719A1 (fr
Inventor
Roger Baurain
Andre Trouet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ire Celltarg SA
Original Assignee
Ire Celltarg SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ire Celltarg SA filed Critical Ire Celltarg SA
Priority to FR8617116A priority Critical patent/FR2607719B1/fr
Priority to FR8702137A priority patent/FR2611138B2/fr
Priority to FR8712424A priority patent/FR2620028B2/fr
Priority to CA000553232A priority patent/CA1338736C/fr
Priority to EP87402747A priority patent/EP0270460B1/fr
Priority to ES87402747T priority patent/ES2070827T3/es
Priority to DE3751258T priority patent/DE3751258T2/de
Priority to AT87402747T priority patent/ATE121301T1/de
Priority to JP62307342A priority patent/JP2852421B2/ja
Publication of FR2607719A1 publication Critical patent/FR2607719A1/fr
Priority to US07/364,481 priority patent/US4973465A/en
Application granted granted Critical
Publication of FR2607719B1 publication Critical patent/FR2607719B1/fr
Priority to MX9203411A priority patent/MX9203411A/es
Priority to HK98106755A priority patent/HK1007502A1/xx
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
FR8617116A 1986-12-05 1986-12-05 Microcristaux comportant a titre de substance active des ginkgolides et compositions pharmaceutiques les contenant Expired - Lifetime FR2607719B1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR8617116A FR2607719B1 (fr) 1986-12-05 1986-12-05 Microcristaux comportant a titre de substance active des ginkgolides et compositions pharmaceutiques les contenant
FR8702137A FR2611138B2 (fr) 1986-12-05 1987-02-19 Microcristaux comportant une substance active presentant une affinite pour les phospholipides
FR8712424A FR2620028B2 (fr) 1986-12-05 1987-09-08 Procede de preparation de microcristaux comportant a titre de substance active, notamment de l'amphotericine b, microcristaux obtenus et composition pharmaceutique en comprenant
CA000553232A CA1338736C (fr) 1986-12-05 1987-12-01 Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
ES87402747T ES2070827T3 (es) 1986-12-05 1987-12-03 Microcristales que contienen una sustancia activa que presenta afinidad por los fosfolipidos y al menos un fosfolipido, procedimiento de preparacion.
DE3751258T DE3751258T2 (de) 1986-12-05 1987-12-03 Mikrokristalle, die eine aktive Substanz mit phospholipidischer Affinität enthalten und mindestens ein Phospholipid, Verfahren zur Herstellung.
EP87402747A EP0270460B1 (fr) 1986-12-05 1987-12-03 Microcristaux comportant une substance active présentant une affinité pour les phospholipides et au moins un phospholipide, procédé de préparation
AT87402747T ATE121301T1 (de) 1986-12-05 1987-12-03 Mikrokristalle, die eine aktive substanz mit phospholipidischer affinität enthalten und mindestens ein phospholipid, verfahren zur herstellung.
JP62307342A JP2852421B2 (ja) 1986-12-05 1987-12-04 燐脂質類に対し、そして少くとも一種類の燐脂質に対して親和性を有する活性物質から成る微結晶、並びにその製造方法及びこの微結晶を含有する薬剤組成物
US07/364,481 US4973465A (en) 1986-12-05 1989-06-08 Microcrystals comprising an active substance having an affinity for phospholipids, and at least one phospholipid, process of preparation
MX9203411A MX9203411A (es) 1986-12-05 1992-06-25 Microcristales que comprenden una substancia activa que tiene una afinidad por los fosfolipidos y por lo menos un fosfolipido, proceso de preparacion
HK98106755A HK1007502A1 (en) 1986-12-05 1998-06-25 Microcrystals containing an active substance with a phospholipid affinity and at least one phospholipid preparation process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8617116A FR2607719B1 (fr) 1986-12-05 1986-12-05 Microcristaux comportant a titre de substance active des ginkgolides et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
FR2607719A1 FR2607719A1 (fr) 1988-06-10
FR2607719B1 true FR2607719B1 (fr) 1991-02-08

Family

ID=9341648

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8617116A Expired - Lifetime FR2607719B1 (fr) 1986-12-05 1986-12-05 Microcristaux comportant a titre de substance active des ginkgolides et compositions pharmaceutiques les contenant

Country Status (1)

Country Link
FR (1) FR2607719B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406713B1 (en) 1987-03-05 2002-06-18 The Liposome Company, Inc. Methods of preparing low-toxicity drug-lipid complexes
US5616334A (en) * 1987-03-05 1997-04-01 The Liposome Company, Inc. Low toxicity drug-lipid systems

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2664380A (en) * 1949-11-02 1953-12-29 Atomic Basic Chemicals Corp Water-dispersible phenothiazine preparation

Also Published As

Publication number Publication date
FR2607719A1 (fr) 1988-06-10

Similar Documents

Publication Publication Date Title
FR2608427B1 (fr) Hydrosols de substances pharmacologiquement actives et compositions pharmaceutiques les contenant
FR2596758B1 (fr) Sels pharmaceutiques d'amlodipine ameliores et compositions pharmaceutiques les contenant
FR2598706B1 (fr) Derives de tetrahydronaphtalene, compositions pharmaceutiques les contenant et procede de preparation
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
MC1968A1 (fr) Procede de preparation de composes antiviraux et procede de preparation de formulations pharmaceutiques les contenant
FR2542312B1 (fr) Composes de sulfonium, leur preparation et compositions pharmaceutiques contenant ces composes
FR2612516B1 (fr) Derives de benzoxazole et preparation les contenant
FR2466248B1 (fr) Derives d'agents anti-inflammatoires non steroides, procede de preparation et compositions pharmaceutiques les contenant
PT84549A (pt) Process for the preparation of macrolide compounds and of anthelmintic acaricidad and insecticidal compositions containing the same
FR2567885B1 (fr) Derives 3-aminopropoxyaryliques, leur preparation, leur application comme medicaments et compositions pharmaceutiques les contenant
FR2624863B1 (fr) Nouvelle forme cristalline de la ciclosporine, sa preparation et les compositions pharmaceutiques la contenant
HUT41800A (en) Process for producing new beta-lactame antibiotica and pharmaceutical compositions containing them as active agents
MC1695A1 (fr) Procedes de preparation de nouveaux composes et de formes pharmaceutiques les contenant
PT85279A (fr) Procede de preparation de derives du nitrofurane et de compositions pharmaceutiques les contenant
FR2645152B1 (fr) 3h-pteridinones-4, procedes de preparation et medicaments les contenant
IL80005A0 (en) Method for modulating cytotoxic effect of tnf and pharmaceutical compositions comprising il-1,tnf and other active materials
BE893193A (fr) Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif
KR890701094A (ko) 활성성분의 피부조직 전이흡수를 보장하는 약제학적 제제형 및 그 조제방법
FR2580632B1 (fr) Ethers cyclopentiliques, leur preparation et formulation pharmaceutiques les contenant
PT83593A (fr) Procede de preparation de 7-acyl-benzoxazinones et leurs derives et de compositions pharmaceutiques les contenant
MA20015A1 (fr) Composes de la benzoyluree et compositions pesticides et pharmaceutiques les contenant
HUT46929A (en) Sposob poluchenija aminoglycoside-steroides and pharmaceutical compositions containing them as active components
PT84933B (fr) Procede de preparation de cyclodepsipeptides et compositions pharmaceutiques qui les contiennent
PT82364B (fr) Procede de preparation de derives du nitrofuranne et de compositions pharmaceutiques les contenant
FR2607719B1 (fr) Microcristaux comportant a titre de substance active des ginkgolides et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property